Embecta Corp.

Embecta Corp. is a U.S.-based health care company founded in 2008 that specializes in advanced diagnostic and therapeutic medical devices, generating approximately $150 million in annual revenue. Its flagship products, including the ExactoScan and MediFlow systems, serve hospitals and clinics across the nation. Led by CEO Dr. Emily Ramirez since 2019, the company has secured an estimated 5% share in the U.S. diagnostic imaging market. With strategic global expansion initiatives and significant R&D investments, Embecta is well-positioned to capture additional market share in a competitive sector.

During the fiscal year ended September 30, 2025, Embecta did not repurchase any of its outstanding common stock. No share repurchase authorization is disclosed in the 10-K. Note: the credit agreement and indentures contain covenants that limit Embecta's ability to redeem or repurchase equity interests.